These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19708812)

  • 21. [Biology of influenza viruses].
    Müller H
    Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):91-100. PubMed ID: 16573199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. To Conquer the Host, Influenza Virus Is Packing It In: Interferon-Antagonistic Strategies beyond NS1.
    Weber-Gerlach M; Weber F
    J Virol; 2016 Oct; 90(19):8389-94. PubMed ID: 27440898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza virus activation of the interferon system.
    Killip MJ; Fodor E; Randall RE
    Virus Res; 2015 Nov; 209():11-22. PubMed ID: 25678267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel Bat Influenza Virus NS1 Proteins Bind Double-Stranded RNA and Antagonize Host Innate Immunity.
    Turkington HL; Juozapaitis M; Kerry PS; Aydillo T; Ayllon J; García-Sastre A; Schwemmle M; Hale BG
    J Virol; 2015 Oct; 89(20):10696-701. PubMed ID: 26246567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways.
    Barchet W; Krug A; Cella M; Newby C; Fischer JA; Dzionek A; Pekosz A; Colonna M
    Eur J Immunol; 2005 Jan; 35(1):236-42. PubMed ID: 15593126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharide: a potent inhibitor of viral-mediated type-I interferon induction.
    Malinoski CP; Marcus PI
    J Interferon Cytokine Res; 2010 May; 30(5):279-82. PubMed ID: 20187774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interspecies transmission, adaptation to humans and pathogenicity of animal influenza viruses].
    Munier S; Moisy D; Marc D; Naffakh N
    Pathol Biol (Paris); 2010 Apr; 58(2):e59-68. PubMed ID: 20303675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of influenza virus infections: the good, the bad and the ugly.
    Kuiken T; Riteau B; Fouchier RA; Rimmelzwaan GF
    Curr Opin Virol; 2012 Jun; 2(3):276-86. PubMed ID: 22709515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
    Cao P; Yan AW; Heffernan JM; Petrie S; Moss RG; Carolan LA; Guarnaccia TA; Kelso A; Barr IG; McVernon J; Laurie KL; McCaw JM
    PLoS Comput Biol; 2015 Aug; 11(8):e1004334. PubMed ID: 26284917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza Virus-Host Co-evolution. A Predator-Prey Relationship?
    Voskarides K; Christaki E; Nikolopoulos GK
    Front Immunol; 2018; 9():2017. PubMed ID: 30245689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of PGRN by influenza virus inhibits the antiviral immune responses through downregulation of type I interferons signaling.
    Wei F; Jiang Z; Sun H; Pu J; Sun Y; Wang M; Tong Q; Bi Y; Ma X; Gao GF; Liu J
    PLoS Pathog; 2019 Oct; 15(10):e1008062. PubMed ID: 31585000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction and suppression of type I interferon responses by mink enteritis virus in CRFK cells.
    Zhang X; Wang J; Mao Y; Xi J; Yu Y; Liu W
    Vet Microbiol; 2017 Feb; 199():8-14. PubMed ID: 28110790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential host response, rather than early viral replication efficiency, correlates with pathogenicity caused by influenza viruses.
    Askovich PS; Sanders CJ; Rosenberger CM; Diercks AH; Dash P; Navarro G; Vogel P; Doherty PC; Thomas PG; Aderem A
    PLoS One; 2013; 8(9):e74863. PubMed ID: 24073225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection.
    Coch C; Stümpel JP; Lilien-Waldau V; Wohlleber D; Kümmerer BM; Bekeredjian-Ding I; Kochs G; Garbi N; Herberhold S; Schuberth-Wagner C; Ludwig J; Barchet W; Schlee M; Hoerauf A; Bootz F; Staeheli P; Hartmann G; Hartmann E
    Mol Ther; 2017 Sep; 25(9):2093-2103. PubMed ID: 28760668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay between host non-coding RNAs and influenza viruses.
    Bamunuarachchi G; Pushparaj S; Liu L
    RNA Biol; 2021 May; 18(5):767-784. PubMed ID: 33404285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-nucleotide methylation specifically represses type I interferon in antiviral innate immunity.
    Gao ZJ; Li WP; Mao XT; Huang T; Wang HL; Li YN; Liu BQ; Zhong JY; Renjie C; Jin J; Li YY
    J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33616624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza A virus TRIMs the type I interferon response.
    Ludwig S; Wolff T
    Cell Host Microbe; 2009 May; 5(5):420-1. PubMed ID: 19454344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Type I Interferon Signaling by
    Thurmond S; Wang B; Song J; Hai R
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30558110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ISRE-Reporter Mouse Reveals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes.
    Uccellini MB; García-Sastre A
    Cell Rep; 2018 Dec; 25(10):2784-2796.e3. PubMed ID: 30517866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy enhances antiviral immunity independent of type I IFN but dependent on IL-17-producing γδ
    Chronopoulos J; Pernet E; Tran KA; McGovern TK; Morozan A; Wang S; Tsai O; Makita K; Divangahi M; Martin JG
    Sci Adv; 2024 Sep; 10(39):eado7087. PubMed ID: 39331716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.